KalVista Pharmaceuticals
KALV
#6279
Rank
A$1.00 B
Marketcap
$20.30
Share price
0.85%
Change (1 day)
26.26%
Change (1 year)

EPS for KalVista Pharmaceuticals (KALV)

EPS in 2023 (TTM): -$4.74

According to KalVista Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$4.94. In 2022 the company made an earnings per share (EPS) of -$5.85 a decrease over its 2021 EPS that were of -$4.17.

EPS history for KalVista Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.74-18.83%
2022-$5.8540.07%
2021-$4.1728.37%
2020-$3.2541.5%
2019-$2.3018.55%
2018-$1.94-49.8%
2017-$3.86
2015-$23.63-6.99%
2014-$25.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.41-31.01%๐Ÿ‡บ๐Ÿ‡ธ USA